Search details
1.
Analysis of acute COVID-19 including chronic morbidity: protocol for the deep phenotyping National Pandemic Cohort Network in Germany (NAPKON-HAP).
Infection
; 52(1): 93-104, 2024 Feb.
Article
in English
| MEDLINE | ID: mdl-37434025
2.
Immunogenicity and reactogenicity of a first booster with BNT162b2 or full-dose mRNA-1273: A randomised VACCELERATE trial in adults ≥75 years (EU-COVAT-1).
Vaccine
; 41(48): 7166-7175, 2023 11 22.
Article
in English
| MEDLINE | ID: mdl-37919141
3.
Plasma exchange with COVID-19 convalescent plasma in a patient with severe ANCA-associated vasculitis and COVID-19 pneumonia after rituximab therapy.
Clin Kidney J
; 15(1): 162-164, 2022 Jan.
Article
in English
| MEDLINE | ID: mdl-35028131
4.
A multinational, phase 2, randomised, adaptive protocol to evaluate immunogenicity and reactogenicity of different COVID-19 vaccines in adults ≥75 already vaccinated against SARS-CoV-2 (EU-COVAT-1-AGED): a trial conducted within the VACCELERATE network.
Trials
; 23(1): 865, 2022 Oct 08.
Article
in English
| MEDLINE | ID: mdl-36209129
Results
1 -
4
de 4
1
Next >
>>